Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Olay Professional Pro-X Performs On Par With Top Rx Brand, At Half The Price?

Executive Summary

Procter & Gamble is going after consumers who demand a bang for their buck with its wrinkle-targeting Olay Professional Pro-X line, which it claims offers Rx results at a much-reduced price
Advertisement

Related Content

In Brief: FDA Cosmetics Twitter; Eyebrow Makeup Sales; Olay ProX Study
Olay Enters Acne Treatment With Pro-X Clear, Formulated For Adults
Olay Enters Acne Treatment With Pro-X Clear, Formulated For Adults
L'Oreal Claim Citing "Genes" Not Misleading, Says U.K. Ad Authority
CellCeuticals To Debut On QVC, Touted As 300% Better Than Competition
In Cosmeceuticals, Price Dictated By Size Of Claim; Scientia Examines Olay
P&G's "Year Of Innovation" Opens With Glimmer Of Recovery
Consumers Trade Down On Skin Care Before Makeup, Scents; Analyst Discusses
When Economy Gets Tough, The Tough Stay Pretty, Retail Execs Tell CEW
Kline Analyst Discusses Importance Of “Real” Innovation During Recession
Advertisement
UsernamePublicRestriction

Register

RS016010

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel